[Clinical investigation of o-(2-hydroxy-3-(tert.-butylamino)-propoxy)-benzonitrile under glucose load by means of continuous recording].
D000284:Administration, Oral; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000494:pharmacology*; D000328:Adult; D001786:Blood Glucose / Q000032:analysis; D002082:Butylamines / Q000008:administration & dosage / Q000494:pharmacology; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D005951:Glucose Tolerance Test; D006207:Half-Life; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D009570:Nitriles / Q000008:administration & dosage / Q000494:pharmacology; D010919:Placebos; D011412:Propanolamines / Q000008:administration & dosage / Q000494:pharmacology*
D000319:Adrenergic beta-Antagonists; D001786:Blood Glucose; D002082:Butylamines; D009570:Nitriles; D010919:Placebos; D011412:Propanolamines
Klinische Prüfung von o-(2-Hydroxy-3-(tert. butylamino)-propoxy)-benzonitril (Kö 1366) unter Glukosebelastung mittels kontinuierlicher Registrierung